
OLD Category: lung disease
February 9, 2021 / Cancer Discov
Non-genetic evolution drives lung adenocarcinoma spatial heterogeneity and progression
February 5, 2021 / J Cyst Fibros
Targeting G542X CFTR nonsense alleles with ELX-02 restores CFTR function in human-derived intestinal organoids
January 21, 2021 / Front Med (Lausanne)
Practical Considerations Relating to Routine Clinical Biomarker Testing for Non–small Cell Lung Cancer: Focus on Testing for RET Fusions
January 11, 2021 / OncoImmunology
A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinoma
January 8, 2021 / Cancer Immunol Immunother
CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma
January 8, 2021 / Sci Immunol
Tissue-resident CD4+ T helper cells assist the development of protective respiratory B and CD8+ T cell memory responses
January 8, 2021 / Cell Mol Immunol
Seedy CD8+ TRM cells in aging lungs drive susceptibility to pneumonia and sequelae
January 1, 2021 / Transl Lung Cancer Res
Simultaneous analysis of ALK, RET, and ROS1 gene fusions by NanoString in Brazilian lung adenocarcinoma patients
December 23, 2020 / Diagnostics (Basel)
RNA-Based Multiplexing Assay for Routine Testing of Fusion and Splicing Variants in Cytological Samples of NSCLC Patients
December 20, 2020 / Mol Oncol